Literature DB >> 1442885

Golgi-Kopsch silver study of the brain of a patient with untreated phenylketonuria, seizures, and cortical blindness.

S Kornguth1, E Gilbert-Barness, E Langer, L Hegstrand.   

Abstract

This report describes the morphological changes observed in the brain of an untreated 27-year-old man with phenylketonuria, cortical blindness, and seizures. Golgi-Kopsch silver, cresyl violet, and hematoxylin and eosin stains were used to study cell structure and organization of the cerebellum, the lateral geniculate nuclei, the visual cortex, frontal cortex, and hippocampus. Extensive neuronal losses occurred in the right lateral geniculate nucleus (LGN), the visual cortex, and hippocampus. The left LGN, cerebellum, and frontal cortex retained neuronal components; there was a reduction in the number of dendritic processes on the Purkinje cells of the PKU subject. The loss of neurons in the LGN and occipital cortex is related to the blindness and the neuronal loss in the hippocampus is related to seizure activity.

Entities:  

Mesh:

Year:  1992        PMID: 1442885     DOI: 10.1002/ajmg.1320440412

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  Sight-threatening phenylketonuric encephalopathy in a young adult, reversed by diet.

Authors:  S Rubin; A L Le Piffer; M B Rougier; M N Delyfer; J F Korobelnik; I Redonnet-Vernhet; C Marchal; C Goizet; S Mesli; C Gonzalez; H Gin; V Rigalleau
Journal:  JIMD Rep       Date:  2013-02-12

2.  Impaired hypercarbic and hypoxic responses from developmental loss of cerebellar Purkinje neurons: implications for sudden infant death syndrome.

Authors:  M Calton; P Dickson; R M Harper; D Goldowitz; G Mittleman
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

3.  The effect of hyperphenylalaninaemia on the muscarinic acetylcholine receptor in the HPH-5 mouse brain.

Authors:  F A Hommes
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

4.  Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients.

Authors:  V Leuzzi; G Trasimeni; G F Gualdi; I Antonozzi
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

5.  Inhibiting neutral amino acid transport for the treatment of phenylketonuria.

Authors:  Adam M Belanger; Malgorzata Przybylska; Estelle Gefteas; Matthew Furgerson; Sarah Geller; Alla Kloss; Seng H Cheng; Yunxiang Zhu; Nelson S Yew
Journal:  JCI Insight       Date:  2018-07-26

6.  Effects of phenylalanine on the survival and neurite outgrowth of rat cortical neurons in primary cultures: possible involvement of brain-derived neurotrophic factor.

Authors:  Duan Li; Xuefan Gu; Lihua Lu; Lili Liang
Journal:  Mol Cell Biochem       Date:  2010-01-27       Impact factor: 3.396

Review 7.  Phenylketonuria.

Authors:  Francjan J van Spronsen; Nenad Blau; Cary Harding; Alberto Burlina; Nicola Longo; Annet M Bosch
Journal:  Nat Rev Dis Primers       Date:  2021-05-20       Impact factor: 52.329

8.  5-Hydroxytryptophan during critical postnatal period improves cognitive performances and promotes dendritic spine maturation in genetic mouse model of phenylketonuria.

Authors:  Diego Andolina; David Conversi; Simona Cabib; Antonio Trabalza; Rossella Ventura; Stefano Puglisi-Allegra; Tiziana Pascucci
Journal:  Int J Neuropsychopharmacol       Date:  2010-11-01       Impact factor: 5.176

9.  High phenylalanine concentrations induce demyelination and microglial activation in mouse cerebellar organotypic slices.

Authors:  Orli Thau-Zuchman; Patrick N Pallier; Paul J M Savelkoul; Almar A M Kuipers; J Martin Verkuyl; Adina T Michael-Titus
Journal:  Front Neurosci       Date:  2022-09-29       Impact factor: 5.152

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.